Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.
about
Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseasesMechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infectionsCytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNATH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism?Regulatory dendritic cells: there is more than just immune activationMetabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid MetabolismInduction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36.The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.Indoleamine 2,3 dioxygenase and metabolic control of immune responses.Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionInduction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.Impairment of T cell function in parasitic infections.Indoleamine 2,3-dioxygenase, tryptophan catabolism, and Mycobacterium avium subsp. paratuberculosis: a model for chronic mycobacterial infections.Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection.Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus InfectionsThe role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infectionAltered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patientsInduction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.Physiologic control of IDO competence in splenic dendritic cellsIndoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cellsInhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionThe role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression.The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase.Protective immunity and vaccination against cutaneous leishmaniasis.Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells.Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.A potential role of indoleamine 2,3-dioxygenase-specific T cells in leishmania vaccination.The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes.Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients.Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis.The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.
P2860
Q21285076-571E39EF-937E-4CDC-B56A-296B9579E13FQ26850457-FBEC86D8-AF75-4E97-92C9-38FBF1B716B2Q27022855-7474C446-ABF3-419C-A81D-9C1A61CCEA12Q27693193-866A38DE-254F-4541-B474-53C785E97AA1Q28388235-9DD34BF0-DB44-4F00-B7BA-A300C7412068Q28548008-7BF7CAD0-AE7E-44C6-ACD0-1AA77B0A1336Q33778936-C99CCB20-E64E-4823-B87D-F938CEB3D7A3Q34219774-1273A01E-D8E1-4E35-BFD4-208751CC450EQ34308495-F198634F-693F-4375-9AB5-98EB6915BCC0Q34617155-86DCD940-7123-4EB1-8E6A-7A84A8CA59B8Q34778943-D7F63E9A-E8E7-4538-B2CF-CF691118C3B5Q35005881-357B6686-2BA0-4DF7-A5AF-7A105B3F81BFQ35097790-1C05CDFA-8D10-467E-AD74-9FCE40CDEEBFQ35191891-4C81F410-0B79-430C-8904-119491173720Q35261125-08E9245B-4FB4-4466-AD16-BFE526176680Q35643823-146CD8A0-E20E-4324-B352-0C20D19354E2Q35719490-E60EB7F8-B19D-4F75-A6FF-CBB62EE61B54Q35770936-F953FBBF-9A73-4780-8A2E-43B4F9E7AF54Q35808796-B2BF8B33-0019-486E-B73A-B64E9E4096A1Q35952614-D6F97448-5C06-4270-93BE-DBAB1B931EFDQ36109720-63CAE728-8BD4-4023-ADA0-BE32EE550217Q36154064-9BF93845-75D6-4697-992E-E4F302F1E8FEQ36265092-1693DB06-1C65-4854-8192-254AF4681590Q36565695-BE428092-A291-4F06-879F-01C268EF054FQ36610873-F0823E81-B70E-48EB-A7D0-8FE817C70AEEQ37006795-B917B30A-041F-4859-80BD-5EBE8DAAE949Q37116807-7FAAAEB9-B4CE-474A-A189-409F26686A48Q37990434-C5AA2673-ED02-40B2-9D48-B0C6BB2A6D5CQ38015852-F2B74DE1-A68A-43CC-AF7A-7285789499DFQ38061723-64B7F4B5-7E0B-4CC8-BE08-DA3A3B6DE762Q38266251-56ED4C57-7E26-4D4C-B4DB-D87DB7007C64Q38293111-72024B67-DC95-490F-8982-3950BD04AE1EQ41927494-AD4BCF0C-A514-4BC8-8D49-CA8BD0F6B4B2Q42274853-7B90964C-3A26-4B3E-AD75-D8ECFAFD3772Q42791145-F950C0F3-37B1-4E18-99A2-169144568041Q44445269-73AEF879-4C2B-42CA-9F7D-6FA476605F13Q45813783-0A2759A5-D2DA-48DA-905C-B489101819BEQ47157913-7043ED1E-45A4-4D2A-AED9-5622D424DC75Q48098105-5CB08C4B-2B92-40DC-9237-68126DF13CB0Q55408705-A668A880-F62B-4C48-BD6A-9E4FB0A963BF
P2860
Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@ast
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@en
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@nl
type
label
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@ast
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@en
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@nl
prefLabel
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@ast
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@en
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@nl
P2093
P2860
P356
P1476
Leishmania major attenuates ho ...... ne 2,3-dioxygenase expression.
@en
P2093
Ahmed R El-Awady
Andrew L Mellor
Babak Baban
David H Munn
De-Yan Hou
Henrique Lemos
Levi H C Makala
Phillip R Chandler
P2860
P304
P356
10.1093/INFDIS/JIQ095
P407
P577
2011-01-31T00:00:00Z